Navigation Links
Testosterone RIA Test

ProductsTestosterone RIA Test
Company Diagnostic Systems Laboratories, Inc.
Item Testosterone RIA Test
Features 
Description Testosterone, (17-Hydroxy-4-androstene-3-one), a C19 steroid, is one of the most potent naturally secreted androgens [1]. In postpubertal males, testosterone is secreted primarily by the testes with only a small amount derived from peripheral conversion of androstenedione [2]. In adult women, it has been estimated that over 50% of serum testosterone is derived from peripheral conversion of androstenedione secreted by the adrenal and ovary, with the remainder from direct secretion of testosterone by these glands [2,3]. The majority of circulating testosterone is bound by SHBG and a smaller portion is bound by albumin. Only 1-2% exists in circulation as unbound or free testosterone [4].

In males, testosterone, either directly or after conversion to DHT, normally functions in fetal Wolffian duct differentiation, development of male external genetalia, stimulation of spermatogenesis, stimulation of anabolic activity in a variety of tissues and, possibly, behavioral and psychological effects [5,6]. In both sexes, testosterone contributes to the development of secondary sexual hair, acne, and scalp hair patterns. In prepubertal males, elevated testosterone levels are found in precocious puberty [7] and in androgen receptor defects [5]. In adult males, low testosterone levels are associated with various pathological conditions, including primary hypogonadism. In females of all ages, elevated testosterone levels can be associated with a variety of virilizing conditions, including adrenal tumors and polycystic ovarian disease [3].

  1. Dorfman RI & Shipley RA. Androgens. JohnWiley and Sons, Inc., New York, 1956, pp. 116-128.
  2. Horton E & Tait JF. J clin Invest 45:301-313, 1966.
  3. Pang S & Riddick L. Hirsutism. IN Lifshitz F (ed). Pediatric Endocronology, A Clinical Guide, second edition. Marcel Dekker, Inc., New York, 1990, pp. 259-291.
  4. Cumming DC & Wall SR. J. Cin Endocrinol Metab 61: 873-876, 1985.
  5. Griffin JE & Wilson JD, The androgen resistance syndroms: 5alpha-reductase deficiency, testicular feminization, and related syndromes. IN: Scriver CR, et al. (eds.): The Metabolic Basis of Inherited Disease, 6th ed. McGraw-Hill, New York, 1989, pp. 1919-1944
  6. Wilson JD. Endocrin Rev 9:181-199,1988.
  7. Holland FJ. Endocrinol Metab Clin North Am 64: 191-210, 1991
Info Diagnostic Systems Laboratories, Inc.
Customer Service: (800) 231-7970
Web site: http://www.dslabs.com

Related medicine products :

1. Testosterone EIA Reproductive Markers 020-DR-1559
2. Free Testosterone EIA Test
3. Ultra-Sensitive Testosterone EIA
4. Testosterone EIA Test
5. Testosterone EIA
6. Testosterone EIA kit
7. Testosterone ELISA
8. Testosterone Enzyme Immunoassay Test Kit
9. Free Testosterone RIA Test
10. Testosterone, Adult Male
11. Testosterone, Bioavailable & Sex Hormone Binding Globulin (Includes Total Testosterone), Adult Male
The new Nellcor N-45 Handheld Pulse Oximeter is compatible with our complete line of OxiMax Pulse Oximetry Sensors, so clinicians have the convenience of Nellcors most advanced sensor technology in a
...or's most popular handheld oximeter has been conve... and is now compatible with the entire line of inn...ehead Sensor and SoftCare Nonadhesive Sensors. The...also incorporates Nellcor's latest advanced signal...
...ellcor N395 Pulse Oximeter with Oxismart XL Advanc...ion conditions, cutting through nonspecific noise ...rate values. , ,The N395 monitor is also equi...ugh in clinician-programmable alarm sensitivity fo...
...e cornerstone of the revolutionary OxiMax® Pul...r combines Nellcor's best-in-class pulse oximetry ... motion-tolerant OxiMax N-595 Pulse Oximeter is eq...ing technology, which enables it to withstand the ...
Medicine Products:
(Date:9/8/2008)...aser scalpels, arthroscopic,surgery, genomic resea...rinary medicine is quickly expanding into new high...e benefit; it,s improving medicine for,people, too... care for their pets to,treat diseases like diabet... according to the American Veterinary Medical Asso...
(Date:9/8/2008)...zine examines Iraq and Afghanistan veterans, strug..., Washington, DC (PRWEB) S...by veterans of the Iraq and Afghanistan wars about... addiction disorders are featured in the current i...ublication of the National Council for Community B...
(Date:9/7/2008)...f older patients successfully treated for colorect...le to detect any recurrence of cancer. The study, ... , a peer-reviewed journal of the American Cancer ...monitoring of colorectal cancer survivors could af...y curative surgery for colorectal cancer have an i...
(Date:9/7/2008)... appear to lower a man,s PSA level, the blood biom...her a man is at risk of prostate cancer. , But t.... 8 in the journal Cancer , caution that men shou... prostate cancer just yet. , "We showed that me...rin and other non-steroidal anti-inflammatory drug...
Breaking Medicine News(10 mins):Health News:High-Tech Vet Medicine Saving Lives of Pets and People 2Health News:Helping Veterans in Our Communities 2Health News:Helping Veterans in Our Communities 3Health News:Many colorectal cancer survivors do not receive recommended follow-up care 2Health News:Common painkillers lower levels of prostate cancer biomarker 2
...ore functions in reproduction than merely being a ...ts that the semen from fertile men contains a mult...cle Stimulating Hormone) initiates ovulation. Some... role in the maintenance of pregnancy. The researc...
...boast of their first FDA-approved pill capable of ...y due to the creation// of a new molecule by a res...tified by the name TMC-114, and also known by the ...molecules that are still under creation by Arun Gh...
...guards and NHS red tape following the Alder Hey bo...dicines, according to researchers//. With restrict...perwork, and seemingly arbitrary judgments by ethi...eterred from getting studies up and running. Jenn...
...e health implication when tiny particles in the ai...er scientists demonstrated that when rats inhale//...ay and make it to many regions in the brain. This ...mental Health Perspectives. There were also eviden...
Other Medicine News:Health News:Finally, The First Ever Treatment for Drug-Resistant HIV 2Health News:Finally, The First Ever Treatment for Drug-Resistant HIV 3Health News:Finally, The First Ever Treatment for Drug-Resistant HIV 4Health News:Medical researchers being stifled by NHS Red tape 2Health News:Nano-sized inhaled particles traverse quickly from nose to brain 2
(Date:9/8/2008)...ept. 8 /- Novo Nordisk (NYS...data from a phase 3 clinical study,(LEAD(TM) 4) to...ociation,for the Study of Diabetes that demonstrat..., a human GLP-1 analog, to metformin and rosiglita... improved blood glucose lowering,(HbA1c), weight l...
(Date:9/5/2008)...TON, Fla., Sept. 5 /PRNewswire-USNewswire/ -- The ... recently awarded Florida,Atlantic University rese...sor and director of the Center for Molecular Biolo...lege of Science, and CHS,Resources LLC (CHS), $184...ercialization Assistance Grant program (SURECAG). ...
(Date:9/5/2008)... Demonstrates microRNAs Extracted From a Simple Bl...Clinical Biomarkers for a Wide Range of ...ary Technology, Rosetta Genomics is Currently Deve...Colon Cancer, REHOVOT, Israel and JERSEY CITY, Ne...setta Genomics, Ltd. (NASDQ: ROSG), a leader in,th...
(Date:9/4/2008)...a Published in ,The Lancet, and Presented at ESC C...esults from a new international,study, the GISSI H...ose of,omega-3 acid ethyl esters reduced all cause...lar reasons in patients with chronic heart,failure...ne version of ,The,Lancet, and were presented at t...
Breaking Medicine Technology:Novo Nordisk New Data From a Phase 3 Study Confirms Clinical Benefits of Once-Daily Liraglutide in the Management of Type 2 Diabetes 2Novo Nordisk New Data From a Phase 3 Study Confirms Clinical Benefits of Once-Daily Liraglutide in the Management of Type 2 Diabetes 3Novo Nordisk New Data From a Phase 3 Study Confirms Clinical Benefits of Once-Daily Liraglutide in the Management of Type 2 Diabetes 4Novo Nordisk New Data From a Phase 3 Study Confirms Clinical Benefits of Once-Daily Liraglutide in the Management of Type 2 Diabetes 5Major State Grant Accelerates Research and Development of Novel Cancer Therapy 2Major State Grant Accelerates Research and Development of Novel Cancer Therapy 3Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 2Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 3Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 4New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 2New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 3New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 4Lettuces Roots Lure Salmonella 3474 1Lettuces Roots Lure Salmonella 3474 2Lettuces Roots Lure Salmonella 3474 3Anticlotting drug found to be safe in sickle cell patients 3472 1Anticlotting drug found to be safe in sickle cell patients 3472 2MIT links gene to cholesterol 761 1MIT links gene to cholesterol 761 2Select Medical Corporation to Announce Third Quarter Results on Monday November 12 3470 1
...abetes Patients -, MONTREAL, March 26 /CNW/ - Co...ounced positive preliminary results from its,Pha...ment of Type 2,diabetes using the Company,s prop...tudy demonstrated that PC-DAC(TM):Exendin-4 was,...ce-weekly at each,of the dosing levels tested, l...
... from ECLIPSE, Largest Safety,Program of Intraveno... 2007 /PRNewswire-FirstCall/ -- Favorable,findings...ipine),compared to current intravenous antihyperte...sion -- a potentially harmful,elevation in blood p...- were presented for the first time at a late-brea...
Other Medicine Technology:PC-DAC:Exendin-4 Phase I/II Multiple-Dose Study Preliminary Results,Demonstrate Safety and Efficacy at Once-Weekly Dosing 2PC-DAC:Exendin-4 Phase I/II Multiple-Dose Study Preliminary Results,Demonstrate Safety and Efficacy at Once-Weekly Dosing 3PC-DAC:Exendin-4 Phase I/II Multiple-Dose Study Preliminary Results,Demonstrate Safety and Efficacy at Once-Weekly Dosing 4Pivotal Phase III Findings With Investigational Drug Cleviprex,(Clevidipine) Demonstrate Perioperative Blood Pressure Control In,Cardiac Surgery 2Pivotal Phase III Findings With Investigational Drug Cleviprex,(Clevidipine) Demonstrate Perioperative Blood Pressure Control In,Cardiac Surgery 3Pivotal Phase III Findings With Investigational Drug Cleviprex,(Clevidipine) Demonstrate Perioperative Blood Pressure Control In,Cardiac Surgery 4Pivotal Phase III Findings With Investigational Drug Cleviprex,(Clevidipine) Demonstrate Perioperative Blood Pressure Control In,Cardiac Surgery 5